Oppenheimer cuts Kyntra Bio target price to $30 from $35
KYNB•Oppenheimer cut its target price for Kyntra Bio to $30 from $35.
Related News

B. Riley cuts AXT target price to $43 from $56
AXTI•

QuinStreet to participate in Roth Technology Conference
QNST•

Ainos enters $9 million equipment sale agreement with ASE
AIMD•

Gran Tierra Energy: Raymond James cuts target price to C$18 from C$19
GTE•

US senators urge FAA to pause new router deployment pending testing
LHX•